{"id":{"repo_id":"birmingham","oai_identifier":"oai:etheses.bham.ac.uk:5018"},"canonical_url":"https://search.ndltd.org/etd/birmingham/oai:etheses.bham.ac.uk:5018","repository":{"repo_id":"birmingham","name":"University of Birmingham","base_url":"https://etheses.bham.ac.uk/cgi/oai2"},"display":{"title":"Elucidating the biological role of silicon and designing a delivery system to enhance early bone mineralisation","abstract":"Silicon has been shown to be an important trace element in bone formation and metabolism, and a decrease in silicon in the mammalian diet leads to abnormal bone formation. Consequently, silicon has been incorporated into many biomaterials to enhance bone generation around implants. Despite this, the mechanism of action has still not been elucidated and a therapeutic dosage has not been determined. In this thesis, the optimum concentration of orthosilicic acid (OSA) to enable cell survival and early mineralisation has been identified. It was noted that a dosage of 5µg/ml of OSA enhanced bone nodule formation. The presence of OSA increased the expression of early osteogenic markers such as osteopontin, osteocalcin and type 1 collagen. In addition, increasing OSA concentration resulted in the development of a collagen fibril network of increasing complexity, up to supraphysiological OSA concentrations when the fibril network became fragmented. It was hypothesised that this may assist with mineral deposition. A sustained delivery system was also developed using a combination of PLGA and calcium silicate. A sustained dose of orthosilicic acid ideal for cell survival was released from the PLGA micro-particles containing calcium silicate. As well as providing a source of OSA, the presence of the alkaline degradation products of calcium silicate aided in the neutralisation of the acidic degradation products of PLGA, which might enhance cell viability in the local environment. In addition to influencing cell behaviour, the OSA was shown to have a strong interaction with alginate, modifying its properties and preventing degradation. This finding is of importance as the molecules comprising alginate bear a structural resemblance to the glycosaminoglycans that are found in the majority of tissues.","abstract_html":"Silicon has been shown to be an important trace element in bone formation and metabolism, and a decrease in silicon in the mammalian diet leads to abnormal bone formation. Consequently, silicon has been incorporated into many biomaterials to enhance bone generation around implants. Despite this, the mechanism of action has still not been elucidated and a therapeutic dosage has not been determined. In this thesis, the optimum concentration of orthosilicic acid (OSA) to enable cell survival and early mineralisation has been identified. It was noted that a dosage of 5µg/ml of OSA enhanced bone nodule formation. The presence of OSA increased the expression of early osteogenic markers such as osteopontin, osteocalcin and type 1 collagen. In addition, increasing OSA concentration resulted in the development of a collagen fibril network of increasing complexity, up to supraphysiological OSA concentrations when the fibril network became fragmented. It was hypothesised that this may assist with mineral deposition. A sustained delivery system was also developed using a combination of PLGA and calcium silicate. A sustained dose of orthosilicic acid ideal for cell survival was released from the PLGA micro-particles containing calcium silicate. As well as providing a source of OSA, the presence of the alkaline degradation products of calcium silicate aided in the neutralisation of the acidic degradation products of PLGA, which might enhance cell viability in the local environment. In addition to influencing cell behaviour, the OSA was shown to have a strong interaction with alginate, modifying its properties and preventing degradation. This finding is of importance as the molecules comprising alginate bear a structural resemblance to the glycosaminoglycans that are found in the majority of tissues.","abstract_has_math":false,"creators":["Birdi, Gurpreet"],"institution":"University of Birmingham","degree_name":"d_ph","degree_level":"d_ph","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2014,"date_issued":"2014-07","date_published":"2014-07","updated_at":"2026-11-19T09:27:58Z","subjects":["TP Chemical technology"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"http://etheses.bham.ac.uk//id/eprint/5018/1/Birdi14PhD.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://etheses.bham.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Aetheses.bham.ac.uk%3A5018","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.sponsor","label":"Sponsor","values":["na"]},{"key":"dc:creator","label":"Author","values":["Birdi, Gurpreet"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2014-07"]},{"key":"dc:date.issued","label":"Date","values":["2014-07"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["College of Engineering & Physical Sciences","School of Chemical Engineering"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Birmingham"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["http://etheses.bham.ac.uk//id/eprint/5018/"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["d_ph"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["d_ph"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["TP Chemical technology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.dcterms_iso639_2","label":"Language (ISO 639-2)","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://etheses.bham.ac.uk//id/eprint/5018/1/Birdi14PhD.pdf","http://etheses.bham.ac.uk//id/eprint/5018/2/Decl_IS_Birdi14PhD.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Silicon has been shown to be an important trace element in bone formation and metabolism, and a decrease in silicon in the mammalian diet leads to abnormal bone formation. Consequently, silicon has been incorporated into many biomaterials to enhance bone generation around implants. Despite this, the mechanism of action has still not been elucidated and a therapeutic dosage has not been determined. In this thesis, the optimum concentration of orthosilicic acid (OSA) to enable cell survival and early mineralisation has been identified. It was noted that a dosage of 5µg/ml of OSA enhanced bone nodule formation. The presence of OSA increased the expression of early osteogenic markers such as osteopontin, osteocalcin and type 1 collagen. In addition, increasing OSA concentration resulted in the development of a collagen fibril network of increasing complexity, up to supraphysiological OSA concentrations when the fibril network became fragmented. It was hypothesised that this may assist with mineral deposition. A sustained delivery system was also developed using a combination of PLGA and calcium silicate. A sustained dose of orthosilicic acid ideal for cell survival was released from the PLGA micro-particles containing calcium silicate. As well as providing a source of OSA, the presence of the alkaline degradation products of calcium silicate aided in the neutralisation of the acidic degradation products of PLGA, which might enhance cell viability in the local environment. In addition to influencing cell behaviour, the OSA was shown to have a strong interaction with alginate, modifying its properties and preventing degradation. This finding is of importance as the molecules comprising alginate bear a structural resemblance to the glycosaminoglycans that are found in the majority of tissues."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public","staffonly"]},{"key":"dc:title","label":"Title","values":["Elucidating the biological role of silicon and designing a delivery system to enhance early bone mineralisation"]}]}],"canonical_facts":{"dc:contributor.sponsor":["na"],"dc:creator":["Birdi, Gurpreet"],"dc:date":["2014-07"],"dc:date.issued":["2014-07"],"dc:description.abstract":["Silicon has been shown to be an important trace element in bone formation and metabolism, and a decrease in silicon in the mammalian diet leads to abnormal bone formation. Consequently, silicon has been incorporated into many biomaterials to enhance bone generation around implants. Despite this, the mechanism of action has still not been elucidated and a therapeutic dosage has not been determined. In this thesis, the optimum concentration of orthosilicic acid (OSA) to enable cell survival and early mineralisation has been identified. It was noted that a dosage of 5µg/ml of OSA enhanced bone nodule formation. The presence of OSA increased the expression of early osteogenic markers such as osteopontin, osteocalcin and type 1 collagen. In addition, increasing OSA concentration resulted in the development of a collagen fibril network of increasing complexity, up to supraphysiological OSA concentrations when the fibril network became fragmented. It was hypothesised that this may assist with mineral deposition. A sustained delivery system was also developed using a combination of PLGA and calcium silicate. A sustained dose of orthosilicic acid ideal for cell survival was released from the PLGA micro-particles containing calcium silicate. As well as providing a source of OSA, the presence of the alkaline degradation products of calcium silicate aided in the neutralisation of the acidic degradation products of PLGA, which might enhance cell viability in the local environment. In addition to influencing cell behaviour, the OSA was shown to have a strong interaction with alginate, modifying its properties and preventing degradation. This finding is of importance as the molecules comprising alginate bear a structural resemblance to the glycosaminoglycans that are found in the majority of tissues."],"dc:format":["application/pdf"],"dc:identifier.uri":["http://etheses.bham.ac.uk//id/eprint/5018/1/Birdi14PhD.pdf","http://etheses.bham.ac.uk//id/eprint/5018/2/Decl_IS_Birdi14PhD.pdf"],"dc:language.dcterms_iso639_2":["eng"],"dc:publisher.department":["College of Engineering & Physical Sciences","School of Chemical Engineering"],"dc:publisher.institution":["University of Birmingham"],"dc:relation.isreferencedby":["http://etheses.bham.ac.uk//id/eprint/5018/"],"dc:subject":["TP Chemical technology"],"dcterms:accessrights":["public","staffonly"],"dc:title":["Elucidating the biological role of silicon and designing a delivery system to enhance early bone mineralisation"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["d_ph"],"dc:type.qualificationname":["d_ph"]},"updated_at":"2026-11-19T09:27:58Z"}